Bausch & Lomb (BLCO) Capital Expenditures Growth (1y) (2022 - 2026)
Bausch & Lomb (BLCO) Capital Expenditures Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 151.46 Bn | 147.07 Bn | 1.83 Bn | -11.41% |
| 2 | Becton Dickinson | 43.06 Bn | 42.04 Bn | 2.15 Bn | 9.65% |
| 3 | Medline | 29.49 Bn | 35.33 Bn | 1.84 Bn | -2.04% |
| 4 | Resmed | 28.58 Bn | 26.92 Bn | 890.98 Mn | 61.83% |
| 5 | West Pharmaceutical Services | 24.11 Bn | 23.59 Bn | 296.40 Mn | -63.39% |
| 6 | Solventum | 14.37 Bn | 14.37 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.38 Bn | 13.25 Bn | 735.40 Mn | 10.63% |
| 8 | Align Technology | 12.72 Bn | 11.66 Bn | 736.59 Mn | 21.73% |
| 9 | Baxter International | 10.32 Bn | 8.27 Bn | 891.00 Mn | 12.30% |
| 10 | Bausch & Lomb | 5.57 Bn | 5.36 Bn | 973.00 Mn | -61.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61.82% |
| Dec 31, 2025 | -17.39% |
| Sep 30, 2025 | 23.33% |
| Jun 30, 2025 | 23.61% |
| Mar 31, 2025 | 64.18% |
| Dec 31, 2024 | 387.50% |
| Sep 30, 2024 | 81.82% |
| Jun 30, 2024 | 166.67% |
| Mar 31, 2024 | 81.08% |
| Dec 31, 2023 | -164.00% |
| Sep 30, 2023 | -32.65% |
| Jun 30, 2023 | -20.59% |
| Mar 31, 2023 | -11.90% |
| Dec 31, 2022 | -19.35% |
| Sep 30, 2022 | 19.51% |
| Jun 30, 2022 | -24.44% |
| Mar 31, 2022 | -6.67% |